Clipping of news on Brazilian Culture, Law and Citizenship
11/01/2013
This article was translated by an automatic translation system, and was therefore not reviewed by people.
FDA wants to halve the dose of sleeping pills for women
WASHINGTON - The FDA, the U.S. agency that regulates food and drugs, said on Thursday that it has asked the manufacturers of the most popular remedies for insomnia in the U.S. as Ambien and Zolpimist to reduce by half the recommended dose for women. Laboratory studies have shown that these drugs can make people drowsy in the morning and at risk of car accidents suffer.
The requirement applies to drugs with the active ingredient zolpidem (in Brazil, the drugs have the Lioram and Stilnox in their formulas), by far the most widely used for the treatment of insomnia. With lower doses, the drug remains in the body for less time in the morning, reducing the risk that a person is debilitated the wheel.
The FDA told the manufacturers that the recommended dose for women who eliminan zolpidem more slowly than men, should be lowered from 10 milligrams to 5 milligrams of immediate use in products. In continuous medication use, the reduction is 12.5 milligrams to 6.25 milligrams. For men, the FDA said labels should recommend smaller doses.
Source: The Globe Online
Our news are removed entirely from the sites of our partners. For this reason, we can not change their content even in cases of typos.
This article was translated by an automatic translation system, and was therefore not reviewed by people.